Thus VDR, which is expressed at a systemic level, may act as a negative tumor suppressor regulator in physiological conditions and could be impaired in cancer patients, thereby promoting cancer transformation and other cancer-related sequelae, including bone health impairment [23,24]. Here, VDR is linked to cancer.